Navigation Links
ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
Date:10/30/2007

EXTON, Pa., Oct. 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) reported today its financial results for the third quarter and nine-months ended September 30, 2007.

Key events since June 30, 2007 include:

Clinical:

-- Patient enrollment began in a Phase 3 study of Camvia(TM) (maribavir)

in liver transplant patients;

-- Patient enrollment continued to the plan in Phase 3 study of Camvia in

stem cell transplant patients; study enrollment expanded to European

sites;

-- Dosing with HCV-796 was discontinued in an ongoing Phase 2 combination

study in hepatitis C patients following discovery of elevated liver

enzyme levels in a subset of patients; trial participants continue to

receive pegylated interferon and ribavirin in this study; and

-- New data presented at the 2007 Interscience Conference on Antimicrobial

Agents and Chemotherapy (ICAAC) meeting by Genzyme Corporation show

Vancocin(R) is superior in clinical success to metronidazole and

Genzyme's experimental compound in patients with severe CDAD (Louie et

al., 2007).

Operational:

-- Net sales of Vancocin(R) were $51 million;

-- Launched new sales and marketing initiatives for Vancocin; and

-- Research and development expenses increased by 40 percent over the

third quarter of 2006, primarily driven by investments in Camvia.

Financial:

-- Operating income was $27.9 million;

-- Working capital increased by $31 million to $573 million;

-- Cash, cash equivalents and short-term investments grew to $552 million;

and

-- 11th consecutive quarter of cash fl
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Autopsy reports could be valuable and informative
3. China reports declining number of SARS Cases
4. Russia Reports First SARS Case
5. Research reports that c-section deliveries are rising
6. Jharkhand reports 13,000 Malaria cases
7. Uganda Reports Failure To Contain Sleeping Sickness
8. WHO reports 36 million deaths world wide due to chronic diseases
9. Reports of Hantavirus infection in India raise concerns
10. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
11. China Reports Yet Another Bird Flu Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 03, 2015 evigilo, a world ... solutions, reported of its "behind-the-scenes" involvement in heroic, ... months. Since March this year, an unusual and ... the South-American country, putting millions in danger. , ... into the atmosphere. "evigilo's technology, adopted by the ...
(Date:6/2/2015)... San Marcos, CA (PRWEB) June 02, 2015 ... a summer special coupon for the months June-September, 2015 along ... wisdom teeth extractions for limited time only. , “Sometimes wisdom ... the soft tissue or jawbone. They can also only partially ... gum tissue. Removal and recovery is easier in young people, ...
(Date:6/2/2015)... June 02, 2015 Concorde Career Colleges, ... President and COO. Bell will manage day-to-day operations for ... looking forward to the opportunity to help our Concorde ... said. “I joined Concorde in part due to reports ... highlighted Concorde colleges in Memphis and Portland.” , Bell ...
(Date:6/2/2015)... Alexandria, VA (PRWEB) June 02, 2015 ... Contact: Erin Wallace, 571-319-9594 (cell) , Email: ewallace(at)mentalhealthamerica(dot)net ... Details of New Mental Health Legislation at MHA ... (PA-18) , What: Rep. Murphy to address the ... details for the long-awaited updated version of the ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 On Wednesday, May ... Supercharged Mustang to a top speed of 207.9 mph. ... 2015 Mustang to break the 200 mph mark. Jay ... filming an upcoming episode of Jay Leno’s Garage, which will ... made on the 8.5 mile high speed oval at the ...
Breaking Medicine News(10 mins):Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Concorde Career Colleges Announces New President and COO 2Health News:Congressman Tim Murphy to Unveil Details of New Mental Health Legislation at MHA Annual Conference Thursday 2Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2
... usually reserved,for lighthearted fun and entertainment, the hallways ... kind of gathering Monday, as child-health,and education experts ... trends in Jordan. Her Majesty Queen Rania Al ... Jordan there, bringing some,welcomed news about the Kingdom,s ...
... estimates 750,000, mostly males, are hooked , , MONDAY, May ... and young adults are problem gamblers according to researchers ... , Problem gambling is defined as gambling associated ... more than you intended or stealing money to gamble. ...
... has targeted an,expansion of its human health and performance ... commercial customers based on the success the,company has had ... other,advanced human support services to the space program., ... human performance and engineering services with an emphasis on,risk ...
... All Natural 100% Juice Superfood Smoothie Line has ,Lifeguard(TM) ... ... Sun Shower(TM) is proud to,introduce a new line of all ... Shower(TM) with the added nutritional,benefits of "Lifeguard(TM) Protection," a fortification package ...
... expansion of serialization initiatives, CRANBURY, N.J., ... Packaging Execution Systems (PES) for the pharmaceutical,industry, ... its sales, central engineering and professional services,teams. ... these areas to support,rapid worldwide deployments; specifically, ...
... Pandemic Influenza Initiatives Also,on the Agenda, WASHINGTON, ... Services (HHS) Secretary Mike Leavitt is visiting the ... efforts to improve the,safety of products on which ... The week-long trip to Beijing and Shanghai includes ...
Cached Medicine News:Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 2Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 3Health News:Queen Rania Launches Situation Analysis of Children in Jordan Highlighting Jordan's Progress in Improving Quality of Life; 6 Ministers Commit to Further Improving Results 4Health News:Problem Gambling Common Among Young Adults 2Health News:Wyle Targets New Customers for Expanded Human Health and Performance Capabilities and Services 2Health News:New Sun Shower(TM) Superfood Smoothies 2Health News:New Sun Shower(TM) Superfood Smoothies 3Health News:Systech Augments Key Departments to Drive Operational Excellence and International Support 2Health News:Systech Augments Key Departments to Drive Operational Excellence and International Support 3Health News:Secretary Leavitt Travels to the People's Republic of China to Check Up on Efforts to Improve Product Safety 2
(Date:6/2/2015)... , June 02, 2015 Research ... addition of the "Laboratory Centrifuges - Global ... Annual estimates and forecasts are provided ... seven-year historic analysis is provided for these markets. ... and secondary research. Company profiles are primarily based ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ... Closures - Global Strategic Business Report" report to their ... the US, Canada , Japan ... , Latin America , and Rest ... for Surgical Incision Closures in US$ Million by the following ...
(Date:6/2/2015)... 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/5tzcx6/specialty_enzymes ... Enzymes - Global Strategic Business Report" report to ... by the following End-Use Applications: Pharmaceutical & Diagnostics, Research/ ... for the US, Canada , ... Asia-Pacific , Latin America ...
Breaking Medicine Technology:Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2Surgical Incision Closures - Global Strategic Business Report 2015 2Specialty Enzymes - Global Strategic Business Report 2015: Indispensable to the Pharmaceutical Industry 2
... CHICAGO--(BUSINESS WIRE)--Jun 23, 2007 - Late breaking ... 67th Annual,Scientific Sessions showed that, when used ... with,metformin provided significant glycemic improvement and was,generally ... with type 2,diabetes. Additional new data from ...
... BOSTON--(BUSINESS WIRE)--Jun 25, 2007 - HepaLife Technologies, ... announced that new,data presented at an international ... cell line outperforms,current cell technologies at replicating ... important step towards the production of,a cell-culture ...
Cached Medicine Technology:Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 2Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 3Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 4Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 5Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 6Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 7Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 8Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 9Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 10Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 11Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 12Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 13Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 14Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 15Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 16Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 17Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 18Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 19Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 20Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 21Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 22Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 23Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 24Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 25Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 26Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 27Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 28Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 29Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 30Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 31Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes 32HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 2HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 3HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 4HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove,Superior at International Conference 5
Enzyme Immunoassay of Factor IX Antigen by ELISA Method, 96 tests....
Enzyme Immunoassay of -Thromboglobulin Antigen by ELISA Method, 96 tests....
Heparin-Platelet Factor 4 Induced Antibody...
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
Medicine Products: